Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 89

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 89
---
We
have secured U.S. Patent No. 9,458,118 (the “CC8464 Patent”), covering the chemical composition and use of our clinical-stage
NaV1.7 blocker. Apart from the CC8464 Patent, we have filed multiple patent applications in foreign jurisdictions, including Canada,
France, India and Japan. It is possible that some of our pending patent applications in foreign jurisdictions will not result
in issued patents in a timely fashion or at all, and even if we are granted the patents we are currently pursuing in foreign jurisdictions,
the patents may not be issued in a form that will provide us with the full scope of protection that we desire, they may not prevent
competitors or other third parties from competing with us, and/or they may not otherwise provide us with a competitive advantage.
Our competitors, or other third parties, may be able to circumvent our patents by developing similar or alternative technologies
or products in a non-infringing manner. For example, there is no assurance that the CC8464 Patent, or any other patent that we
may be granted, will prevent third parties from developing competing technologies. Moreover, our patent estate, including the
CC8464 Patent, does not preclude third parties from obtaining intellectual property rights that could interfere with our freedom
to use our platform for other indications. Even assuming patents issue from our pending and future patent applications, changes
in either the patent laws or interpretation of the patent laws in the United States and foreign jurisdictions may diminish the
value of our patents or narrow their scope of protection.

We
have pending patent applications for both of CT2000 and CT3000 and there is no guarantee that any of these applications become
patents in the United States or any other jurisdiction.

We
may not be able to protect our intellectual property or enforce our intellectual property rights adequately throughout the world.

Filing
and prosecuting patent applications on CC8464, CT2000, CT3000 and future new compounds, current and future innovations related
to our technology, and our institutional knowledge in all countries throughout the world would be prohibitively expensive, and
intellectual property protections available in some countries outside the United States, and the enforceability thereof, may differ
in scope from those in the United States. Thus, in some cases, we will not seek to obtain patent protection for certain technologies
in some jurisdictions outside the United States. In addition, the laws of some foreign countries do not protect intellectual property
to the same extent as federal and state